Clinical trial
Carmat Total Artificial Heart Early Feasibility Study
NCT04117295 is registered in ClinicalTrials.gov with Carmat SAS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carmat Total Artificial Heart Early Feasibility Study
- Lead sponsor
- Carmat SAS
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- July 12, 2021
- Completion date
- January 31, 2027
- Enrollment
- 10 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
end-stage heart failure